Inducers/inhibitors [Regulatives / Guidelines]

posted by Ohlbe – France, 2024-08-08 20:09 (287 d 18:13 ago) – Posting: # 24143
Views: 2,420

Dear Helmut,

❝ In a FDC half lives of components are generally different. In a drug with two isomers the half lives are likely different as well. Therefore, #2 because the washout was long enough for the respective other drug / isomer.


Yes, but... what if the drug which is still detected induces or inhibits the metabolism of the drug which is no longer detected ?

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,679 registered users;
47 visitors (0 registered, 47 guests [including 22 identified bots]).
Forum time: 14:22 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5